Pancreatic Cancer Research

ResearcherMax Planck Institute of BiochemistryNo recent work listed

Jonathan J. Swietlik

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5005159571. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. Co-author DOI 10.1038/s41467-023-38171-8↗
  2. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Co-author DOI 10.1038/s43018-021-00326-1↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefanie Bärthel · 2 shared papers, 2022–2023 · strength 0.27
  2. Chiara Falcomatà · 2 shared papers, 2022–2023 · strength 0.27
  3. Felix Meissner · 2 shared papers, 2022–2023 · strength 0.27
  4. Dieter Saur · 2 shared papers, 2022–2023 · strength 0.27
  5. Constantin Schmitt · 1 shared paper, 2022 · strength 0.10
  6. Christian Schneeweis · 1 shared paper, 2022 · strength 0.10
  7. Woo Hyun Paik · 1 shared paper, 2022 · strength 0.10
  8. Maximilian Reichert · 1 shared paper, 2022 · strength 0.10
  9. Bernhard Küster · 1 shared paper, 2022 · strength 0.10
  10. Roland Rad · 1 shared paper, 2022 · strength 0.10
  11. Günter Schneider · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.